Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Boehringer Ingelheim
Express Scripts

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021618

« Back to Dashboard

NDA 021618 describes TINDAMAX, which is a drug marketed by Mission Pharma and is included in one NDA. It is available from four suppliers. Additional details are available on the TINDAMAX profile page.

The generic ingredient in TINDAMAX is tinidazole. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tinidazole profile page.

Summary for 021618

Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 021618


Medical Subject Heading (MeSH) Categories for 021618

Suppliers and Packaging for NDA: 021618

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TINDAMAX tinidazole TABLET;ORAL 021618 NDA Mission Pharmacal Company 0178-8250 0178-8250-40 40 TABLET, FILM COATED in 1 BOTTLE (0178-8250-40)
TINDAMAX tinidazole TABLET;ORAL 021618 NDA Mission Pharmacal Company 0178-8500 0178-8500-20 20 TABLET, FILM COATED in 1 BOTTLE (0178-8500-20)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:May 17, 2004TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:May 17, 2004TE:ABRLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: